Envista Holdings Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29415F1049
USD
20.13
-0.32 (-1.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1250173,
    "name": "Envista Holdings Corp.",
    "stock_name": "Envista Holdings Corp.",
    "full_name": "Envista Holdings Corp.",
    "name_url": "stocks-analysis/envista-holdings-corp",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "20.13",
    "chg": -0.32,
    "chgp": "-1.56%",
    "dir": -1,
    "prev_price": "20.45",
    "mcapval": "3,514.74",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US29415F1049",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.23 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/envista-holdings-corp-1250173-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Envista Holdings Corp. Experiences Evaluation Revision Amidst Mixed Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/envista-holdings-corp-sees-valuation-grade-shift-from-expensive-to-attractive-3649144",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/EnvistaHoldings_valuationdot_3649144.png",
        "date": "2025-10-27 16:11:45",
        "description": "Envista Holdings Corp. has recently adjusted its valuation, with its stock price slightly increasing. Over the past year, the company has experienced a stock return of 7.05%, lagging behind the S&P 500. Key financial metrics reveal a mixed valuation landscape compared to industry peers, indicating diverse financial health within the sector."
      },
      {
        "title": "Is Envista Holdings Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-envista-holdings-corp-technically-bullish-or-bearish-3548041",
        "imagepath": "",
        "date": "2025-09-20 20:08:27",
        "description": "As of 12 September 2025, the technical trend for Envista Holdings Corp. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating some positive momentum. The Bollinger Bands also reflect a bullish stance on the weekly and mildly bullish on the monthly. Daily moving averages are bullish, supporting the overall mildly bullish outlook. However, the OBV shows a mildly bearish trend on the monthly, which could signal some caution.\n\nIn terms of performance, Envista has underperformed the S&P 500 over the past week and year, with returns of -2.68% and 9.65% respectively, compared to the S&P 500's returns of 1.05% and 17.14%. Overall, the current technical stance is mildly bullish, but the mixed signals suggest a need for careful monitoring...."
      },
      {
        "title": "Is Envista Holdings Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-envista-holdings-corp-overvalued-or-undervalued-3544218",
        "imagepath": "",
        "date": "2025-09-20 18:40:48",
        "description": "As of 7 August 2025, the valuation grade for Envista Holdings Corp. has moved from expensive to attractive, indicating a shift towards a more favorable assessment. The company is currently considered undervalued, supported by a P/E ratio of 73, an EV to EBITDA of 13.83, and a Price to Book Value of 1.05. In comparison to peers, QIAGEN NV has a P/E of 24.20, while Masimo Corp. shows a significantly higher P/E of 179.74, reinforcing Envista's relative attractiveness.\n\nDespite the positive valuation outlook, Envista's recent stock performance has lagged behind the S&P 500, with a year-to-date return of 9.02% compared to the index's 12.22%. Over the past three years, the stock has declined by 38.69%, while the S&P 500 has gained 70.41%, highlighting the need for cautious optimism regarding its future performance...."
      },
      {
        "title": "Envista Holdings Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/envista-holdings-corp-technical-trend-changes-from-bullish-to-mildly-bullish-amid-mixed-outlook-3522910",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/EnvistaHoldings_technicaldot_3522910.png",
        "date": "2025-09-16 19:01:22",
        "description": "Envista Holdings Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has seen its stock price rise slightly to $21.13. The company has experienced significant volatility over the past year, with a 52-week high of $23.00 and a low of $14.22, reflecting mixed technical indicators and varying performance compared to the S&P 500."
      }
    ],
    "total": 9,
    "sid": "1250173",
    "stock_news_url": "https://www.marketsmojo.com/news/envista-holdings-corp-1250173"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock newsNews and Views
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available